Racial and Sociodemographic Disparities in Hepatitis C Treatment at an Urban Academic Medical Center, 2018-2023.

ABSTRACT:

Background

Hepatitis C virus (HCV) disproportionately affects racial minorities and socially disadvantaged groups in the United States. Despite highly effective direct-acting antiviral (DAA) therapies, treatment disparities persist.

Methods

We conducted a retrospective cohort study using electronic medical record data from both inpatient and outpatient settings in an urban academic medical center between 1 October 2018 and 1 October 2023. Multivariable logistic regression identified sociodemographic and clinical predictors of HCV treatment initiation, defined as a documented direct-acting antiviral prescription, among individuals with positive HCV RNA between 2018 and 2023.

Results

Among 4345 individuals, 1150 (26.5%) were prescribed HCV treatment. Black individuals w

SUBMITTER: Elnaiem AD 

PROVIDER: S-EPMC12164289 | biostudies-literature | 2025 Jun

REPOSITORIES: biostudies-literature